Close Menu

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    EU fossil fuel bill jumps as Middle East conflict bites

    April 14, 2026

    Man City beat Chelsea to revive Premier League race

    April 13, 2026

    EU carbon market emissions fall 1.3% in 2025

    April 11, 2026
    Trending
    • EU fossil fuel bill jumps as Middle East conflict bites
    • Man City beat Chelsea to revive Premier League race
    • EU carbon market emissions fall 1.3% in 2025
    • Moscow opens T2 on record urban tram route
    • European wheat extends losses on ample global supply
    • European Commission says Hormuz passage must stay free
    • UK set for warmest day of 2026 before sharp cooldown
    • Russian study finds spruce compounds slow blood clotting
    • Home
    • Contact Us
    Evening Post LondonEvening Post London
    Tuesday, April 14
    • Automotive
    • Business
    • Entertainment
    • Health
    • Lifestyle
    • Luxury
    • News
    • Sports
    • Technology
    • Travel
    Evening Post LondonEvening Post London
    Home » Your Trusted Bridge to MENA Regulatory Success and Market access for Pharma, Cosmetics, and Medical Devices
    Featured News

    Your Trusted Bridge to MENA Regulatory Success and Market access for Pharma, Cosmetics, and Medical Devices

    May 5, 2025
    Facebook WhatsApp Twitter Pinterest LinkedIn Telegram Tumblr Email Reddit VKontakte

    Newszy: Dubai, UAE – As global pharmaceutical, cosmetic, and medical device companies set their sights on expanding into the rapidly growing MENA region, market momentum is stronger than ever. The GCC pharmaceutical sector alone was valued at $23.7 billion in 2024 and is projected to nearly double to $48.98 billion by 2033, with a CAGR of 7.6%. Likewise, the cosmetics market is expected to grow from $8.5 billion in 2024 to $14.4 billion by 2033, while the medical devices sector is set to rise from $17.15 billion in 2024 to $36.21 billion by 2035.  PRA Consultancy founded in 2013 as one of UAE pioneering healthcare regulatory consultancies, PRA Consultancy has successfully delivered over 10,000 projects, building a reputation for precision, speed, and unwavering reliability. With a remarkable 100% success rate in securing product registrations across the region, PRA Consultancy continues to turn complex regulatory requirements into seamless pathways for market access and sustained growth. Here’s how we help you thrive in this dynamic landscape:

    • Minimize Risk, Maximize Success: We reduce the risk of rejection by ensuring meticulous alignment with the latest health authority expectations.
    • Bridge the Cultural and Regulatory Gap: Our deep understanding of both global and regional frameworks eliminates delays and misalignment.
    • Clear Communication, No Misinterpretations: With multilingual experts on your side, we simplify complex guidelines and eliminate language barriers.
    • Local Insights, Strategic Entry: Our market intelligence and strong regional presence pave the way for smarter, faster decision-making.
    • Faster Registration, Smoother Approvals: We streamline timelines with precision planning and proactive follow-ups.
    • On-Ground Support You Can Trust: From licensing to representation, we handle the complexity so you can focus on growth.
    • Unified Strategy Across Borders: Our cross-country expertise ensures consistency, clarity, and compliance every step of the way.

    PRA solves these challenges with localized insight, multilingual professionals, and a proven methodology grounded in regional know-how and regulatory foresight.

    Full-Spectrum Regulatory Services

    PRA delivers bespoke support in:

    • Pharmaceutical Regulatory Affairs – Strategic advice, dossier preparation, and lifecycle management for drug products
    • Medical Device Compliance – Navigating classification, risk assessments, clinical evaluation, and CE-mark aligned submissions
    • Cosmetics & Aesthetic Regulatory Affairs – Ingredient assessments, product registration, labelling, and claims compliance
    • Biotech & Biopharma Compliance – Tailored regulatory solutions for novel therapies and biosimilars
    • F&B and Food Supplement Compliance – Ensuring safe and legal market entry for nutraceuticals and health-focused products
    • International Strategy – Harmonizing EU/FDA experience with MENA authority expectations

    Unmatched Market Access & Local Presence

    Whether helping a U.S. pharmaceutical brand launch in Saudi Arabia within three months, or enabling European cosmetic leaders to scale quickly across the GCC,
    PRA’s turnkey solutions and deep regulatory relationships deliver unmatched value. The consultancy acts as your local agent,
    managing the end-to-end regulatory process while allowing clients to retain flexibility with multiple distributors.

    Why Global Leaders Trust PRA

    • 100% regulatory approval track record
    • Multilingual, culturally aligned team
    • Comprehensive support across MENA & GCC
    • Time and cost-efficient strategies
    • Transparent, ethical, and multilingual workforce
    • Deep authority engagement and dynamic mapping of new guidelines
    • Capability to build regulatory departments from the ground up
    • Real-time mapping of guidelines and regulatory intelligence

    By bridging the cultural, linguistic, and regulatory divide, PRA Consultancy enables companies to launch faster, safer, and smarter with the confidence
    of knowing every guideline is correctly interpreted and every submission is strategically framed for success.

    Your Gateway to the MENA Region

    As global interest in MENA healthcare markets grows, PRA Consultancy is uniquely positioned to help international companies realize their expansion goals.
    From regulatory affairs for pharmaceutical products to cosmetics and medical device compliance, PRA transforms complexity into clarity.

    Contact: PRA Consultancy
    📍 Dubai, UAE
    🌐 www.pra-me.com
    ✉️ info@pra-me.com
    Tel: + 97142999398

    Related Posts

    “Aqaar” and “Dusit International” Launch “Dusit Thani Residences Ajman” to Establish New Standards for Luxury Residential Communities in the Emirate

    February 13, 2026

    Dubai showcases applied green AI for urban sustainability

    January 26, 2026

    Dubai emerges as policy and innovation hub for green AI

    January 26, 2026

    Dubai to host inaugural international conference on Green AI in January 2026

    January 22, 2026

    MENA Newswire launches always-on client reporting with SpyderAPI

    December 18, 2025

    MENA Newswire automates multilingual content publishing in 19 nations

    October 3, 2025
    Latest News

    EU fossil fuel bill jumps as Middle East conflict bites

    April 14, 2026

    Man City beat Chelsea to revive Premier League race

    April 13, 2026

    EU carbon market emissions fall 1.3% in 2025

    April 11, 2026

    Moscow opens T2 on record urban tram route

    April 11, 2026

    European wheat extends losses on ample global supply

    April 11, 2026

    European Commission says Hormuz passage must stay free

    April 11, 2026

    UK set for warmest day of 2026 before sharp cooldown

    April 8, 2026

    Russian study finds spruce compounds slow blood clotting

    April 8, 2026
    © 2024 Evening Post London | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.